Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPAR.L Regulatory News (PAR)

  • There is currently no data for PAR

Issue of Equity

9 Feb 2011 14:30

RNS Number : 9549A
Noventa Limited
09 February 2011
 



Noventa Limited

("Noventa" or the "Company")

Issue of Equity

9 February 2011

The Company has today issued 245,260 ordinary 0.04p shares ("Ordinary Shares") as performance bonuses to three members of the Board of Directors (the "Bonus Issue"), all of whom have elected to receive 100% of their bonus in shares. Pat Lawless has received 191,610 Ordinary Shares, Tim Griffiths has received 26,825 Ordinary Shares and Guy Coltman has received 26,825 Ordinary Shares.

The following table sets out details of Director's Shareholdings (as defined in the AIM Rules) of the Company following the Bonus Issue.

Ordinary Shares

Held

Percentage of Issued Ordinary Shares Held

 

Kean Chung ***

5,862,404

1.15%

Eric Kohn TD *

5,441,629

1.07%

John Allan **

3,093,282

0.61%

Pat Lawless

872,560

0.17%

Dr Joachim Martin

414,610

0.08%

Tim Griffiths

226,127

0.04%

Guy Coltman

171,717

0.03%

Leslie Heymann

27,190

0.01%

* These shares are held by Barons Financial Services Limited, a company in which Mr. Kohn has a beneficial interest.

** These shares are held by Ekasure Limited, a company in which Mr. Allan has a beneficial interest

*** 5,500,000 of these shares are held by a family trust of which Mr. Chung is a potential beneficiary

The following table sets out details of Significant Shareholders (as defined in the AIM Rules) of the Company, to the extent that the Company is aware, following the Bonus Issue.

Ordinary Shares Held

 

Percentage of Issued Ordinary Shares Held

Highland African Ventures Limited #

79,373,079

15.59%

Richmond Capital LLP

39,556,000

7.77%

Kaizan Capital LLC

26,648,900

5.23%

Panta Holdings BV

21,367,911

4.20%

Compagnie Internationale de Participations Bancaires et Financieres SA

19,906,340

3.91%

JMM Trading LP

16,769,507

3.29%

# Highland African Ventures Limited is owned by a trust whose trustee is Fleming Family & Partners Liechtenstein and Mr. R J Fleming is one of the potential beneficiaries. Fleming Family & Partners Liechtenstein has a total interest, including through Highland African Ventures Limited, in a total of 89,203,154 shares (17.52% of the issued shares). Mr. R J Fleming has an interest, including through Highland African Ventures Limited, in a total of 85,208,892 shares (16.73 % of the issued shares).

An application has been made to admit the new Ordinary Shares issued under the Bonus Issue to trading on AIM, with trading expected to commence on 14 February 2011.

Following the Bonus Issue, the Company will have 509,205,732 Ordinary Shares in issue and following the issue of all of the 9,953,171 Additional Subscription Shares (as defined in the Company's 'Issue of Equity' announcement of 3 September 2010) the Company will have 519,158,903 Ordinary Shares in issue. The Company does not hold any Ordinary Shares in treasury.

For further information please contact:

Eric F. Kohn TD

Chairman

Noventa Limited

+41 22 8500560

+41 79 5030150

www.noventa.net

 

Nick Harriss/Emily Staples

Religare Capital Markets (Nomad)

+44 20 7444 0800

 

Andrew Chubb/Kit Stephenson

Canaccord Genuity Limited (Joint Broker):+44 20 7050 6500

 

Daniel BriggsReligare Capital Markets (Joint Broker)+44 20 7444 0500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSTLMJTMBJMBFB
Date   Source Headline
22nd Sep 20147:00 amRNSStrategy Change and Issue of Convertible Loan Note
9th Jun 20148:30 amRNSIssue of convertible loan notes
3rd Jun 20147:00 amRNSChange of Registered Office
26th Mar 20147:30 amRNSSuspension - Paragon Resources plc
26th Mar 20147:00 amRNSStatement re. Suspension
25th Mar 20147:01 amRNSHolding in Company
19th Mar 20147:00 amRNSIssue of Equity
3rd Mar 201410:15 amRNSIssue of Equity
24th Feb 20147:00 amRNSAcquisition of interest in Paragon Volta Limited
6th Feb 201410:45 amRNSDirector Shareholding
3rd Feb 201410:46 amRNSHalf Yearly Report
10th Jan 20143:00 pmRNSHolding in Company
27th Nov 201312:25 pmRNSResult of AGM
21st Nov 20137:00 amRNSIssue of Equity
4th Nov 20133:30 pmRNSNotice of AGM
30th Oct 201311:00 amRNSInvestment in Greenstar, Appointment of CEO etc...
3rd Sep 201310:00 amRNSIssue of Equity
22nd Aug 20132:16 pmRNSAppointment of special adviser to the Board
12th Aug 20137:00 amRNSCancellation of contract & appointment of Director
8th Aug 20137:00 amRNSIssue of Equity
30th Jul 201310:28 amRNSFinal Results and appointment of Director
24th Jul 20134:26 pmRNSResult of Class Meeting
17th Jul 201312:45 pmRNSAdjournment of class meeting
11th Jul 20134:35 pmRNSPrice Monitoring Extension
24th Jun 201311:30 amRNSUpdate on Sales Process
21st Jun 20133:00 pmRNSIssue of Equity & Change of Name
19th Jun 20132:12 pmRNSResult of EGM
12th Jun 20132:16 pmRNSAdjournment of Class Meeting and EGM
3rd Jun 201311:00 amRNSUpdate Sale Process
15th May 201311:08 amRNSNotice of EGM
11th Apr 201310:00 amRNSDirectorate Change and Settlement Agreement
18th Mar 201311:16 amRNSIssue of Equity and Trading Update
1st Mar 20137:00 amRNSUpdate on Operations
11th Feb 20137:41 amRNSProduction update
5th Feb 201312:15 pmRNSCease to be reporting issuer in Canada
17th Jan 20137:00 amRNSPreference Share Dividend
28th Dec 20123:21 pmRNSShipment of Tantalum Pentoxide Concentrate
14th Dec 20121:00 pmRNSCease to be a reporting issuer in Canada
29th Nov 201212:00 pmRNSHolding(s) in Company
28th Nov 20127:00 amRNSOperations Update
23rd Nov 20127:00 amRNSCompletion of Secured Loan Financing Agreement
20th Nov 20128:39 amRNSLoan Extension
9th Nov 20123:59 pmRNSLoan Extension
1st Nov 201211:11 amRNSLoan Extension
11th Oct 20127:00 amRNSPreference Share Dividend
28th Sep 201212:45 pmRNSLoan Extension
28th Sep 20127:00 amRNSHalf Yearly Report
11th Sep 20127:00 amRNSDirectorate Change
31st Aug 20129:37 amRNSLoan Extension
17th Aug 20124:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.